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ABSTRACT 
 
BACKGROUND: Successful management of furcation involved tooth is a clinical 
challenge. Closure of furcation defects is the most desirable outcome of therapy to 
ensure optimal maintenance and long-term success.  Attempts at regenerative therapy 
based on the concept of guided tissue regeneration (GTR) can result in significant 
improvements in clinical parameters, bone fill and closure of defects. Various 
biomaterials have been employed over years to achieve this goal. 
AIM:  Purpose of the present study is to assess clinically and radiographically the 
regenerative capacity of 0.2% hyaluronic acid gel in conjunction with chorion GTR 
membrane in Grade II furcation defects. 
MATERIALS AND METHOD: A total of 10 subjects with clinical and 
radiographic evidence of Grade II furcation involvement, indicated for regenerative 
periodontal surgery were selected. After completion of phase I therapy, an open flap 
debridement was done at the defect site. Hyaluronic acid gel 0.2% (Gengigel
®
) was 
applied into the defect followed by placement of chorion membrane. Plaque index 
(PI), gingival bleeding index (GBI), probing pocket depth (PPD), horizontal probing 
depth (HPD), clinical attachment level (CAL) and radiographic defect depth (DD) 
were recorded at baseline, 3 months and 6 months.  
RESULTS: Healing was uneventful in all patients. At 6 months, significant 
improvements were observed in PI and GBI with mean differences of 1.5±0.10 and 
50.85±4.49 respectively. The probing depth measurements revealed a mean difference 
of 5.2±0.24 at 6 months, similarly, the CAL and HPD recordings demonstrated mean 
differences of 4.9±0.27 and 4.2±0.24 respectively. A statistically significant decrease 
was observed in the mean radiographic DD values at 3 months and 6 months, 
indicating the defect closure. The mean bone fill (in mm) was 1.19±0.45 at 3 months 
and 2.7±0.33 at 6months, accounting to a mean bone fill percentage (%) of 
40.73±14.98 at 3 months and 91.2±6.11 at 6 months. Statistically highly significant 
improvements were attained in all the clinical and radiographic parameters at 3 
months and 6 months (p< 0.05). 
CONCLUSION: Within the limitations of this study, it could be concluded that the 
combined use of 0.2% hyaluronic acid gel and chorion GTR membrane resulted in 
significant improvements in all the clinical and radiographic parameters evaluated at 
all time intervals with near complete defect closures at 6 months. However, controlled 
clinical trials are required with larger sample size and long-term follow-up to validate 
the regenerative capabilities of these materials where, histologic evaluation and 
surgical re-entry would be more appropriate methods to confirm the findings.  
KEY WORDS: Furcation Defects, Regenerative periodontal therapy, 0.2% 
Hyaluronic acid gel, Chorion membrane, Guided tissue regeneration. 
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INTRODUCTION 
Periodontitis by definition is “an inflammatory disease of the supporting structures of 
the teeth caused by specific microorganisms or groups of specific microorganisms, 
resulting in progressive destruction of the periodontium”1. Periodontal diseases are 
considered to be one of the most prevalent diseases and are the major cause of tooth 
morbidity and mortality
2
. Hence, the ultimate goal of periodontal therapy is to arrest 
the progression of disease and to achieve a healthy and functional periodontium that 
helps in the long term maintenance of the dentition. 
 Furcation involvement (FI) is an important complication in the progression of 
periodontitis and increases the risk of tooth loss. The management of multi-rooted 
teeth demonstrating furcation invasion is one of the greatest clinical challenges to the 
periodontist. This is attributed to their complex anatomy that makes accessibility 
difficult for daily hygiene efforts as well as instrumentation during treatment. The 
suggested treatment modalities for furcation defects include odontoplasty, open flap 
debridement, regeneration, root resection, and extraction
3
. Attempts at regenerative 
therapy can result in favourable outcomes such as bone fill and closure of defects. 
With the introduction of bioactive agents, such as platelet concentrates, enamel matrix 
derivatives, bone morphogenic proteins, and matrix macromolecules such as 
hyaluronic acid, the scope for better outcomes in furcation treatment has surfaced.  
Hyaluronic acid, a glycosaminoglycan, is a principal constituent of the extracellular 
matrix. It significantly contributes to tissue hydrodynamics, cell migration, and 
proliferation. Hyaluronate has shown anti-inflammatory, anti-edematous, and anti-
bacterial properties, which suggests their use for resolution of gingivitis and 
periodontitis. It is osteoconductive and accelerates bone regeneration by means of 
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chemotaxis, proliferation, and successive differentiation of mesenchymal cells
4
. 
Hence, its application to periodontal defects could achieve favourable results in 
regeneration.  
In 1976, Melcher presented the basic concepts of compartmentalisation, which led to 
the development of the clinical technique known as guided tissue regeneration (GTR). 
This treatment modality allows for the formation of bone, cementum, and periodontal 
ligament in the degranulated periodontal defects by placement of a membrane which 
acts by selective prevention of epithelial cells from populating periodontal defects. 
Various non-resorbabale and resorbable barrier membranes have been used for this 
purpose and recent addition to the list of GTR membranes are the foetal membrane 
(amnion-chorion membrane). They act by encouraging rapid epithelial cell growth 
rather than epithelial exclusion. As epithelial cells quickly migrate across the amnion-
chorion membrane (ACM) barrier, they from a seal over the underlying bone graft 
and do not apically migrate into the defect. They harbour pluripotent stem cells which 
have the ability of transdifferentiation to other cellular elements of periodontium 
making them suitable candidate for GTR
5
. Apart from this, the foetal membrane lacks 
immunogenicity, possesses variety of collagen types (I, III, IV, V, and VI) and growth 
factors (platelet-derived growth factor-a (PDGF-a), PDGF-b, fibroblast growth factor 
(FGF), and transforming growth factor (TGF)-β) that provide a bioactive matrix to 
facilitate wound healing. They also have anti-bacterial and anti-inflammatory 
properties
6
. These unique features make them an ideal reservoir for regeneration and 
repair. 
In the present study, two novel biomaterials, 0.2% hyaluronic acid gel and chorion 
GTR membrane (foetal membrane) were used to treat Grade II furcation defects in 
mandibular molars. 
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AIM 
The present study was carried out with an aim to assess clinically and 
radiographically the regenerative capacity of 0.2% hyaluronic acid gel in conjunction 
with chorion guided tissue regeneration (GTR) membrane in Grade II furcation 
defects. 
 
 
OBJECTIVES 
 To compare the pre-treatment clinical parameters with the clinical parameters 
obtained at 3 months and 6 months, following treatment with 0.2% hyaluronic 
acid gel in conjunction with chorion membrane in Grade II furcation defects  
 To radiographically evaluate the bone fill obtained at 3 months and 6 months, 
following treatment with 0.2% hyaluronic acid gel in conjunction with chorion 
membrane in Grade II furcation defects.  
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REVIEW OF LITERATURE 
FURCATION DEFECTS 
A furcation invasion / involvement (FI) has been defined by the American Academy 
of Periodontology as the pathologic resorption of bone in the anatomic area of a 
multi-rooted tooth where the roots diverge. It typically occurs due to the progression 
of chronic or aggressive periodontitis
7
.  
The anatomy of the furcation area includes:                                                                                                                                                                                        
Furcation entrance: Transitional area between undivided and divided part of the root. 
Furcation fornix: The roof of the furcation.  
Degree of separation: The angle of separation between the roots.  
Divergence: It is the distance between two roots which normally increases in apical 
direction. 
The intricate anatomy and variable morphology of the furcation not only provides an 
environment favourable for bacterial plaque retention, but also limits the access for 
instrumentation. This is because, a high percentage of mandibular first molars have 
furcation entrance width values ≤ 0.75 mm. These values are smaller than the width of 
common curettes, which means that such instruments cannot debride the surface of 
the furcation entrance area adequately
8
. Another feature of molar anatomy is the root 
separation area. The measurement of this area tends to increase apically 
demonstrating the divergence of roots. When the inter-radicular separation is ≥ 2mm, 
it is associated with better furcation healing after regenerative therapies
9
. 
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The presence of furcation involvement indicates advanced periodontal disease and 
poses the challenge of a questionable prognosis for the affected tooth. In a landmark 
study by Hirschfeld and Wasserman
10
, it was observed that teeth with furcation 
involvement exhibited a higher rate of tooth loss (31%) compared to teeth without 
furcation defects (7%) over a period of ≥15 years. In addition, several studies have 
demonstrated that FI tooth responded less favourably to non-surgical therapy than 
tooth without FI 
11,12
.  
Prevalence and distribution: 
Furcation involvement is frequently more common in maxillary molars than in 
mandibular molars (Ross & Thompson 1980, Svardstrom & Wennstrom 1996, 
Dannewitz et al., 2006). A study by Ross and Thompson (1980) found that the 
prevalence of furcation involvement in maxillary molars was 90%; compared with 
35% in mandibular molars. Studies on dry skulls have found that maxillary first and 
second molars have a higher risk for furcation involvement than mandibular molars. 
Moreover, first molars were more frequently affected than second molars (Larato 
1970, Tal & Lemmer 1982). According to Svardstrom (1996), highest frequency of 
furcation involvement is the distal of maxillary 1st molar (53%) and lowest frequency 
of furcation involvement is the mesial of the maxillary 2nd molar (20%) 
Etiology 
The etiology of furcation involvement maybe classified into three major groups
13
. 
1. Primary factor - Bacterial plaque, most common etiologic factor 
2. Predisposing factors - Location relative to cementoenamel junction (CEJ), root 
trunk length, root length, root form, interradicular dimension, furcation shape, 
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location of entrance, furcation entrance diameter, facial and lingual radicular 
bone, enamel projections, enamel pearls, bifurcation ridges, root concavities, 
and carious lesions. 
3. Contributing factors - plaque-associated inflammation, trauma from occlusion, 
pulpal pathology, vertical root fractures, and iatrogenic factors. 
Diagnosis
13 
1. Clinical Assessment 
2. Probing: Buccal and lingual furcation can be easily probed. Proximal 
furcations are difficult for probing particularly when broad contacts are 
present in adjacent teeth. Nabers Probe and Columbia curette 4R/4 L are used 
for probing the furcation area 
3. Bone Sounding or Transgingival probing: It may aid in the diagnosis of 
furcation defects more accurately determining the underlying bone contours. 
4. Radiographic Assessment- Radiographs have been used to determine the 
presence or absence of FI with different results (Rees et al., 1971, Deas et al., 
2006). Rees et al., found that 86% of the buccal and lingual furcation can be 
diagnosed with the aid of radiographs. Deas et al., found that the agreement 
on detection of proximal FI between clinical and radiographic examination 
was 38.7% and the agreement on the absence of FI was 92.2%.  
Classification 
A number of classifications have been proposed to categorize furcation involvement 
(summarized in Table 1)
14-21
. 
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Table 1: Various Classifications proposed for Furcation Involvement  
 
AUTHOR(S) 
 
CLASSIFICATION 
 
 
1958 Glickman
14
 
 
Grade I: soft tissue lesion extending to the entrance of the furcation but no furcal bone 
loss 
Grade II: loss of furcal bone to varying degrees but not through and through 
Grade III: through and through but not clinically visible (presence of granulomatous 
tissue) 
Grade IV: through and through visible clinically (tunnel) 
 
 
1958 Goldman
15
 
 
 
Grade I: incipient 
Grade II: cul-de-sac (pouch) 
Grade III: through and through 
 
 
 
1969 Staffileno
16
 
 
Grade I: soft tissue lesion extending to the entrance of the furcation with minor degree of 
bone loss 
Grade II: loss of furcal bone but not through and through 
Grade III: through and through 
 
 
 
1969 Easley and 
Drennan
17
 
 
Class I: incipient involvement, entrance of the furcation detectable with no horizontal 
bone loss 
Class II, Type 1: horizontal bone loss but no vertical component 
Class II, Type 2: horizontal bone loss and vertical bone loss 
Class III, Type 1: through-and-through bone loss with no vertical component 
Class III, Type 2: through-and-through bone loss with vertical component 
 
 
1975 Hamp et al., 
18
 
 
 
Degree/Class I: horizontal loss of periodontal tissue support <3 mm 
Degree/Class II: horizontal loss of periodontal tissue support >3 mm but not through and 
through 
Degree/Class III: through-and-through defect 
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1979 Ramfjord
19
 
 
Degree 1: horizontal penetration <2 mm 
Degree 2: horizontal penetration >2 mm but not through and through 
Degree 3: through and through 
 
 
 
 
1982 Ricchetti 
 
Class I. 1 mm of horizontal measurement; the root furrow. 
Class Ia. 1–2 mm of horizontal invasion; earliest damage. 
Class II. 2–4 mm of horizontal invasion. 
Class IIa. 4–6 mm of horizontal invasion 
Class III. > 6 mm of horizontal invasion. 
 
 
 
1984 Tarnow and  
Fletcher 
20
 
 
Uses Grades I, II, III proposed previously by Glickman with an additional sub-
classification based on vertical invasion from the furcation fornix: 
A: VPD, 1 to 3 mm 
B: VPD, 4 to 6 mm 
C: VPD, >7 mm 
 
 
 
 
 
1998 Hou et al.,
21
 
 
Three classes (Class I, II, and III): 
Classes are the same as Grades in the classification by Hamp et al., Two subclasses 
(Subclass a and b): 
a: for suprabony defects 
b: for infrabony defects 
Three types (A, B, and C): 
A: root trunk represents the cervical one-third of the root complex 
B: root trunk represents half of the root complex 
C: root trunk represents the cervical two-thirds of the root complex 
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The present study deals with Grade II furcation defects, as classified by Glickman, 
demonstrating loss of furcal bone to varying degrees but not through and through. 
Nevertheless, the classification by Hamp et al., is probably the most universal one. 
This is likely attributable to its simplicity and the correlation between the proposed 
degrees of severity and commonly found clinical scenarios; also, it is the most 
commonly used classification in periodontal research. 
Management 
The treatment or correction of a furcation invasion is dependent on several factors 
such as, the severity of furcation invasion, amount of remaining bone support, status 
of abutment teeth, and strategic importance of the involved tooth.  Grade I lesions 
frequently respond well to conservative therapy that involves odontoplasty, non-
surgical therapy, and minimal flap surgery. Grade III/ IV lesions are managed by 
surgical therapy such as Widman flaps or tunnel preparations, root resections, and 
hemisection. Grade II furcation defects respond well to regenerative therapies.  
In a recent systematic review by Avila-Ortiz et al., (2015)
22
,
 
it was concluded that the 
indication of regenerative approaches for the treatment of furcation defects is 
predictable in certain clinical scenarios, particularly in maxillary facial or 
interproximal and mandibular facial or lingual Class II furcation defects. Regenerative 
therapy in maxillary molars presenting Class III furcation defects and in maxillary 
premolars affected by Class II or III furcation defects is not predictable based on 
current available evidence. The authors also stated that, novel approaches such as, 
tissue engineering-based approaches consisting of the application of biologic agents, 
growth factors, scaffolds, pluripotential cells or a combination of them should be 
encouraged in future. 
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Regeneration is defined as the reproduction or reconstitution of a lost or injured part 
in such a way that the architecture and function of the lost or injured tissues are 
completely restored. With the advent of guided tissue regeneration (GTR) based on 
the concept given by Melcher, restoration of periodontium is being achieved more 
predictably. The technique using barrier was introduced by Nyman in 1982, and the 
term GTR was coined by Gottlow in 1986. GTR is employed with the use of 
resorbable and non-resorbable membranes which act as a physical barrier to avoid 
connective and epithelial tissue down-growth into the defect, thereby favouring the 
regeneration of periodontal tissues.  
The barrier membranes recommended for use in GTR must satisfy the following 
criteria (Greenstein G, Caton JG 1993)
23
 
1. Biocompatibility 
2. Cell occlusiveness  
3. Space making  
4. Tissue integration  
 5. Clinical manageability 
CLASSIFICATION OF BARRIER MEMBRANES (SV Madhuri 2016)
24
 
Membranes used for periodontal regeneration can be classified as  
A) 1. Nonresorbable           expanded-Poly Tetrafluoroethylene (e-PTFE) Gore-Tex  
                                            High density poly tetrafluoroethylene (d-PTFE)  
                                            Titanium mesh Titanium reinforced PTFE 
     2. Resorbable                 Polymeric ( vicryl, atrisor, Epiguide) & collagen derived 
 
Review of Literature 
 
11 
 
 
B) According to generation  
 
1. First generation membranes  
                               Cellulose acetate (Millipore)  
                               Expanded Poly Tetra FluoroEthylene (e-PTFE), Gore Tex.  
                               Titanium reinforced ePTFE.  
                               High-density- PTFE 
                               Titanium mesh 
 
 2. Second Generation Membranes 
                               Natural collagen or chitosan.  
                               Synthetic membranes -  polyesters (e.g. polyglycolic acid -PGA)  
                                                                      Polylactic acid (PLA)  
                                                                      Polycaprolactone (PCL) and their co-  
                                                                      polymers  
3. Third Generation Membranes  
                       I) Barrier membranes with Antimicrobial activity  
                               Amoxicillin, Tetracycline, 25% Doxycycline, Metronidazole.  
                       II) Barrier membranes with Bioactive Calcium Phosphate incorporation   
                               Nano-sized hydroxyapatite (HA) particles  
                               Nano-carbonated hydroxyapatite (nCHAC).  
                     III) Barrier membranes with Growth Factor release.  
                                Fibroblastic growth factor (FGF-2), Transforming growth factor   
                                (TGF),  
                                Bone Morphogenic Protein (BMP-2, 4,7 and 12) and                      
                                Enamel Matrix Derivative (EMD) 
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CHORION MEMBRANE 
The foetal/placental membranes belong to the third generation GTR membranes. 
Their historical background is described as follows (Ira Gupta et al., 2014)
25
:  
 Davis, 1910 - introduced the use of human foetal membranes for skin 
transplantation   
 Sabella and Stern, 1913 - described use for burns and ulcerated skin surfaces  
 De Roth, 1940 - first reported use  of foetal membranes in the ocular surface  
 Douglas, 1952 -  use of amniotic membrane  to temporarily cover burn 
wounds  
 Lawson, 1985 -  amniotic membrane with pectoralis major muscle for oral 
cavity reconstruction  
 Early 1980’s - interest in amniotic membrane waned due to risk of 
communicable diseases  
 Late 1990’s and early 2000’s - amnion reappeared in cryopreserved form for 
the treatment of ophthalmic wounds  
From then on, it is applied in various fields of medicine, including management of 
burns, reconstruction of the bladder and vagina, tympanoplasty, arthroplasty, and so 
on. Use of placental allografts in dentistry is a more recent development. 
Review of literature indicates that the amnion-chorion membranes provide good 
results in terms of root coverage, as barrier membrane for furcation and intrabony 
defects, intra oral soft and hard tissue healing, increasing width of attached gingiva, 
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enhancement of gingival biotype, excellent aesthetics in terms of texture and colour 
match. 
The foetal membrane is a bio-mechanical GTR membrane. Fulfilling the traditional 
concept of mechanical GTR, it maintains the structural and anatomical configuration 
of regenerated tissues. Fulfilling the modern concept of biologic GTR,  it contributes 
to the enhancement of healing through reduction of postoperative scarring, subsequent 
loss of function and provides a rich source of stem cells
26
.  
Foetal membranes are associated with the developing foetus and are comprised of 
amnion and chorion tissues. The chorion forms the outer limits of the sac that 
encloses the foetus (Figure 1) and is composed of different types of collagen and cell 
adhesion bioactive factors
27, 28
. The chorion membrane has numerous advantages 
because of its structure and composition. 
 
Figure 1:  Developing foetus 
Structurally, it consists of the following layers (Figure 2):  
1) Reticular Layer 
2) Basement Membrane; and  
3) Trophoblasts (Bourne G, 1962)
29
.  
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Figure 2: Structure of chorion membrane 
The extracellular matrix comprises collagen Types I, III, IV, V, and VI and cell-
adhesion bioactive factors, such as fibronectin and laminin (Suresh DK, Gupta A. 
2013)
28
. Collagen is well tolerated and bioabsorbable, has hemostatic properties, and 
encourages migration of adjacent autogenous connective tissue
30
. Fibronectin is 
involved in many cellular processes, including tissue repair, blood clotting, cell 
migration, and adhesion
31
. Laminin has a high affinity for binding epithelial cells, and 
in contrast to traditionally available membranes, this membrane allows for rapid 
epithelial cell growth rather than epithelial exclusion (Baum BJ, Wright WE., 
1980)
32
. Additionally, the matrix of the chorion contains abundant growth factors, 
such as keratinocyte growth factor (KGF), basic fibroblast growth factor (FGF), and 
transforming growth factor (TGF)-β that promote periodontal regeneration33, 34 and 
provide a natural environment for accelerated healing
6
. Furthermore, the ability of this 
allograft to self-adhere eliminates the need for suturing, thus making it easier to use in 
posterior defects.  
Despite being allografts, the occurrence of acute rejection after transplantation of 
foetal membranes is negated by the fact that amniotic epithelial cells do not express 
HLA-A, HLA-B, HLA-D, and HLA-DR antigens but express HLA-G on their 
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surfaces, which plays a role in immune-tolerance during pregnancy. As tissue grafts 
of placental membrane materials present a low risk of immune rejection, they are 
considered to be bestowed with“immune privilege”.35,36 
 
STUDIES ON FOETAL MEMBRANES 
PRE-CLINICAL STUDIES 
Initially, studies were done with use of amnion- chorion membranes and amnion 
membrane, recently there is an equal focus of interest to studies using chorion 
membrane. 
Gomes et al., in 2001 studied the use of foetal grafts to line the floors of cortical bone 
defects and to cover the superficial surface of the defects. At 90 days, amnion tissue 
was in direct apposition to newly formed bone
37
. At 120 days, the amnion tissue grafts 
were no longer present and bone had completely filled the defects. The authors 
concluded that the use of placental tissue grafts did not inhibit repair in guided bone 
regeneration and may have been beneficial for its antibacterial properties. 
Rinastiti et al., in 2006 
38
 histologically evaluated the use of amnion tissue in thirty 
3-4-month-old rabbits. Amnion tissue grafts in this study were made by layering 5 
sheets (5 × 5mm) of freeze-dried, human amniotic membrane. Half of the wounds 
were covered with amnion grafts and the other half of the wounds served as the 
uncovered, control group. Compared to the control group, the amnion treated wounds 
had fewer polymorphonuclear cells at days 1 and 3; thicker epithelium and more 
fibroblasts at days 5, 7, and 10; statistically significant greater new blood vessel 
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formation at days 7 and 10; and significantly more mature and dense collagen fibers at 
day 10. 
The treatment of oral mucositis in rats with placental membrane was studied by 
Vilela-Goulart et al., in 2006 
39
. The amnion treated group demonstrated 
hypercellularity, including endothelial cells and fibroblasts, and intense vascularity. In 
addition, amnion treated group had accelerated healing as compared to non-amnion 
treated group. 
These three in vivo studies, utilizing placental grafts in oral cavity applications, 
demonstrated some distinct advantages. First, there was no graft rejection, despite the 
xenograft nature of the amnion in two of these three studies. Secondly, amnion grafts 
accelerated healing, while reducing inflammation and acting as a bacterial barrier. 
Lastly, no interference with bone growth was observed in a model for guided bone 
regeneration. 
 
CLINICAL STUDIES 
Guler et al., in 1997
40
 studied the use of a single layer of lyophilized, gamma 
irradiated amnion for vestibuloplasty in 20 patients. All patients showed some edema, 
which resolved by day 7.On day 10, epithelialisation of the graft was observed and the 
amnion graft could not be differentiated. Smooth granulation tissue covered the 
grafted areas by day 14; and the amnion had completely degraded. At day 21, the 
grafted areas were completely covered with oral mucosa. In addition, blood flow to 
the alveolar mucosa was measured in patients by clearance of intramucosal injections 
of radioactive xenon gas. At day 10, a significant increase in blood flow in the graft 
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was detected, compared with the preoperative state. At 30 days, the blood flow 
decreased and was not significantly different from normal levels. A similar study by 
Basa et al., in 1987
41
, which used autologous palatal grafts, showed that the blood 
flow to the grafted area decreased at day 10 and did not return to normal blood flow 
for 4 weeks postoperatively. At 6 weeks, the blood flow continued to increase and the 
tissue appeared lighter in color than surrounding mucosa. Guler et al., in 1997
40
 
proposed that the angiogenic property of the amnion grafts resulted in more rapid 
revascularizations and subsequent epithelialization of the grafted areas. Hence, 
healing period for the amnion grafts was significantly shorter.  
Samandari et al., in 2004 suggested that the amniotic membrane might be used as a 
potential graft material for vestibuloplasty
42
. 
Gurinsky in 2009 
43 
reported results of a series of five patients treated with foetal 
membranes for shallow-to moderate Miller Classes I and II recession defects . At 12 
weeks, an increase in newly generated gingival tissue of 3.2mm ± 1.7mm was 
measured. Coverage was 100% in four out of five patients and 88% in the fifth 
patient. 
SV Kothiwale et al., in 2009
44
 clinically and radiographically evaluated and 
compared the efficacy of demineralised freeze-dried bone allograft and bovine 
derived xenogeneic bone graft with amniotic membrane in the treatment of human 
periodontal Grade II buccal furcation defects. Results showed significant pocket depth 
reductions, clinical attachment level gains, and significant improvement in bone fill 
and percentage gain with both of the materials. 
Wallace in 2010
45
 evaluated clinically and histologically the efficacy of a new 
resorbable, immunoprivileged, self-adhering amniotic membrane for ridge 
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preservation following tooth extraction. Quality of the histologically evident bone 
formed at 4.5 months was excellent. There was no evidence of resorption of crestal 
bone height and inflammation, which suggests the potential benefits of using amniotic 
allograft in guided bone regeneration. 
Arai et al., in 2011
46
 showed the clinical usefulness of the hyper-dry amniotic 
membrane as an intraoral wound dressing material. The results suggested that it is 
biologically acceptable to oral wounds and could be a suitable clinical alternative for 
the repair of the oral mucosa. 
Rosen in 2011
47
 used a combined approach for correcting both the hard- and soft-
tissue deformities around a maxillary canine that included a mineralized bone 
allograft, recombinant platelet derived growth factor, and a chorion amnion barrier 
covered by a subepithelial connective tissue graft. The advantages of this particular 
barrier are that it is extremely thin, measuring 300μm after full hydration, with the 
major noncollagenous components being laminins, proteoglycans, and fibronectin, 
further enhancing its tissue friendly nature. 
Holtzclaw and Toscano in 2013
6
 used amnion- chorion membrane as a barrier for 
regeneration in the treatment of periodontal intrabony defects in localised moderate to 
severe chronic periodontitis cases. All patients were treated by thorough 
degranulation of intrabony periodontal defects and placement of bone allograft 
covered by amnion-chorion membrane. Clinical measurements 12 months after 
surgery revealed an average probing depth reduction of 5.06±1.37mm and clinical 
attachment level improvement of 4.61±1.29 mm. These membranes being thin in 
diameter (300μm) have an advantage over other collagen membranes (700–800 μm) 
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used in guided tissue regeneration. They adapt better to anatomy of defects and root 
contours
48
. 
The use of chorion membrane for root coverage and gingival biotype enhancement 
was reported by D.K. Suresh and Akanksha Gupta, 2013 
28
 . Gingival thickness 
was augmented by 1mm together with 100% root coverage, which was in harmony 
with the adjacent tissues. Because chorion consists of various adhesion molecules, 
such as laminins, there was no need to suture the membrane, thus making it even 
easier to use. Unlike cadaveric allograft, xenograft, and alloplast barrier membranes, 
placental allografts have an advantage because they are composed of 
immunoprivileged tissue, possess antibacterial and antimicrobial properties, reduce 
inflammation at the wound site, and provide a protein-enriched matrix to facilitate cell 
migration
49
. 
Shaila V. Kothiwale, 2013
50
 demonstrated the effect of chorionic membrane (CM) in 
GTR in periodontal pocket therapy. Ten patients with moderate to severe periodontitis 
were selected in the single blind randomized controlled clinical trial. Patients were 
treated with periodontal pocket therapy along with CM in study sites and the control 
sites were treated with periodontal pocket therapy alone. The clinical parameters were 
recorded at baseline and 12 months. The radiographic parameters were recorded at 
baseline, 6 and 12 months. Statistical significant differences were found in both sites 
at 12 months for GI, PI, PPD and CAL. An increased bone gain(BG) was observed in 
study sites. It was concluded that GTR using a bioabsorbable CM in periodontal 
pocket therapy demonstrated greater BG and good tissue integrity in clinical and 
radiographic evaluations than periodontal pocket therapy alone. 
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Shetty et al., in 2014
51
 compared usage of Platelet-rich Fibrin (PRF) and amniotic 
membrane in bilaterally occurring multiple Miller Class I recession. Complete root 
coverage was observed with both of the membranes but the results were stable even 
after seven months in the amniotic membrane-treated site. 
Janice Esteves et al., 2014
52
 reported the efficacy of human chorion membrane 
allograft for recession coverage in ten subjects. The results of this case series indicate 
a stable result at 6 months as evidenced by a reduction in PPD along with a gain in 
CAL, which could be attributed to the regenerative potential of the membrane. There 
was no significant change in gingival recession height between 3 and 6 months, and 
an increase in width of keratinised gingiva (WKG) was noted as early as 3 months, 
along with a resultant thicker gingival biotype. It is known that, once the stability of 
the soft tissue margin has been obtained at the level of the CEJ, the keratinised tissue 
is able to increase with time. The significant gain in WKG and the improvement in the 
biotype may also be attributed to the presence of mitogenic factors and anti-
inflammatory proteins. 
Ridge preservation using demineralized freeze‑dried bone allograft and chorion 
membrane was reported by Shah R et al., 2014
53
. The authors stated that CM was 
used as an alternative to conventional collagen membrane which resulted in excellent 
esthetics and prevention of tissue loss postoperatively. Also, an improved gingival 
biotype was obtained which is more disease‑resistant and stable. 
Sonali Chakraborthy et al., 2015
54
 compared and evaluated the efficacy of amnion 
membrane and chorion membrane in combination with coronally advanced flap in the 
treatment of gingival recessions. The results indicated that both amnion membrane 
and chorion membrane showed improvements in the various clinical parameters 
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including, decrease in recession depth, recession width, increase in width of attached 
gingiva, gain in attachment level and excellent gingival colour match but chorion 
membrane had better handling properties compared to amnion membrane as chorion 
is thicker than amnion membrane. 
Mahajan et al., 2015 
55
 performed guided tissue regeneration based treatment of root 
coverage using placental membrane allograft and concluded that placental membranes 
have certain additive advantages over other membranes and can be used as an 
alternative to collagen membrane. Rich source of stem cells, enhancement of healing 
and self-adhering property make these membranes an effective option for root 
coverage procedure. 
Shaila Kothiwale et al., 2016
56
 enhanced gingival biotype through chorion 
membrane with innovative step in periodontal pocket therapy. The patients in age 
group between 25 and 45 years with chronic periodontitis, indicated for flap surgery 
were selected for the study. The sites with pocket depth of 6–8 mm in the mandibular 
anterior teeth were divided into test and control sites. Periodontal flap surgery was 
carried at both the sites and chorion membrane was placed at the test sites. The 
gingival thickness measurement was assessed using a markings marked on injection 
needle, these markings were read using digital vernier caliper, pre and post 
operatively. The baseline values of gingival thickness at test site (1.04 ± 0.19 at mid 
buccal region, 1.24 ± 0.20 at mid papillary) and control site (0.94 ± 0.11 at mid buccal 
region, 1.14 ± 0.11 at mid papillary region) showed no statistically significant 
difference. At test sites, 6 weeks post treatment (1.36 ± 0.16 at mid buccal region and 
1.48 ± 0.17 at mid papillary region) as compared to control sites (1.06 ± 0.11 at mid 
buccal region, 1.24 ± 0.11 at mid papillary) showed statistically significant increase in 
gingival thickness (p ≤ 0.05*). The authors concluded that, the innovative step of 
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placement of chorion membrane during periodontal pocket therapy facilitated increase 
in the gingival thickness in the areas with thin gingival biotype. 
 
HYALURONIC ACID GEL 
HISTORICAL BACKGROUND 
Hyaluronic acid was discovered in 1934 by Karl Meyer and his colleague John 
Palmer, scientists at Columbia University, New York, who isolated a chemical 
substance from the vitreous jelly of cow's eyes
57
.They proposed the name hyaluronic 
acid as it was derived from Greek word hyalos (glass) and contained two sugar 
molecules one of which was uronic acid. 
STRUCTURE 
Hyaluronic acid (HA) is naturally occurring non sulphated glycosaminoglycan with 
high molecular weight of 4,000- 20,000,000 daltons. HA structure consists of 
polyanionic disaccharide units of glucouronic acid and N-acetylglucosamine 
connected by alternating β1–3 and β1–4 bonds (Figure 3). It is a linear polysaccharide 
of the extracellular matrix of connective tissue, synovial fluid, embryonic 
mesenchyma, vitreous humor, skin and many other organs and tissues of the body. 
Most cells of the body are capable of synthesizing hyaluronic acid and synthesis takes 
place in the cell membrane. Hyaluronan binds to many other extracellular matrix 
molecules, binds specifically to cell bodies through cell surface receptors, and has a 
unique mode of synthesis in which the molecule is extruded immediately into the 
extracellular space upon formation
58
. Extensive studies on the chemical and 
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physicochemical properties of HA and its physiological role in humans have proved 
that it is an ideal biomaterial for cosmetic, medical, and pharmaceutical applications.
 
 
Figure 3: Structure of Hyaluronic acid 
In the field of dentistry, preliminary clinical trials have been conducted by Pagnacco 
and Vangelisti in 1997
59
. HA has shown anti-inflammatory, anti-oedematous, and 
anti-bacterial effects for the treatment of periodontal disease, which is mainly caused 
by the microorganisms present in subgingival plaque. It has been found that the 
equilibrium between the free radicals/reactive oxygen species (ROS) and antioxidants 
is the major prerequisite for healthy periodontal tissue. Individuals suffering from 
periodontitis might be at a higher risk of developing other systemic inflammatory 
diseases like cardiovascular diseases and diabetes
60
. Sardi 2013 suggested that the co-
existence of periodontal disease and diabetes could pathologically increase the effect 
of oxidative stress
61
. While, Pendyala et al., 2013, found that the total antioxidant 
capacity is inversely proportional to the severity of inflammation and can be used as a 
useful marker of periodontitis in health and diabetic patients
62
. HA has the ability to 
scavenge free radicals and hence, it is also conceivable that HA administration to 
periodontal wound sites could achieve beneficial effects in periodontal tissue 
regeneration and periodontal disease treatment
63
. 
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PROPERTIES 
1. Hygroscopic nature 
Hyaluronic acid is one of the most hygroscopic molecules known in nature. When HA 
is incorporated into aqueous solution, hydrogen bonding develops between adjacent 
carboxyl and N-acetyl groups; this feature allows hyaluronic acid to maintain 
conformational stiffness and to retain water. One gram of hyaluronic acid can bind up 
to 6 L of water. As a physical background material, it has functions in space filling, 
lubrication, shock absorption, and protein exclusion (Sutherland IW 1998)
64
. 
2. Viscoelastic properties 
The viscoelastic properties of the material may slow the penetration of viruses and 
bacteria, a feature of particular interest in the treatment of periodontal diseases. 
Hyaluronan as a viscoelastic substance assists in periodontal regenerative procedures 
by maintaining spaces and protecting surfaces
64
. Through recognition of its 
hygroscopic and viscoelastic nature, hyaluronic acid can influence the cell functions 
that modify the surrounding cellular and extracellular micro and macro environments. 
FUNCTIONS 
1. Modulation of inflammation 
 Enhanced inflammatory cell and extracellular matrix cell infiltration into the 
wound site 
 Elevation in pro-inflammatory cytokine production by inflammatory cells and 
extracellular matrix cells. 
 Organization and stabilization of granulation tissue matrix. 
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 Scavenges reactive oxygen species, such as superoxide radical (·O2) and 
hydroxyl radical (·OH) thus preventing periodontal destruction. 
 Inhibition of inflammatory cell-derived serine proteinases (Weigel PH et al., 
1988)
65
. 
2. Stimulation of cell migration, proliferation, and differentiation 
The remarkable hydrophilicity of hyaluronic acid makes the coagulum more receptive 
and thus more likely to undergo colonization by the cells committed to the 
reconstruction of the damaged tissue by migration, proliferation and differentiation of 
mesenchymal and basal keratinocytes ( Toole BP 2001 )
66
. 
3. Effect on angiogenesis
 
Deed R et al., 1997 
67
, studied the effect of hyaluronan on angiogenesis and stated 
that low molecular weight hyaluronic acid has a marked angiogenic effect whereas, 
surprisingly, high molecular weight has the opposite effect. 
4. Osteoconductive potential 
Hyaluronic acid accelerates the bone regeneration by means of chemotaxis, 
proliferation and successive differentiation of mesenchymal cells. Hyaluronic acid 
shares bone induction characteristics with osteogenic substances such as BMP-2 and 
osteopontin (Mendes RM et al., 2008)
68
. 
5. Carrier function 
Hyaluronic acid may act as biomaterial scaffold for other molecules, such as BMP-2 
and PDGF-BB, used in guided bone regeneration techniques and tissue engineering 
research (Hunt DR et al., 2001)
69
. 
6. Bacteriostatic effect 
Recent studies on regenerative surgical procedures indicate that reduction of bacterial 
burden at the wound site may improve the clinical outcome of regenerative therapy. 
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The high concentration of medium and lower molecular weight hyaluronic acid has 
the greatest bacteriostatic effect, particularly on Aggregatibacter 
actinomycetemcomitans, Prevotella oris and Staphylococcus aureus strains commonly 
found in oral gingival lesions and periodontal wounds (Pirnazar P et al., 1999)
70
.  
 
CLINICAL APPLICATIONS IN PERIODONTICS
71 
 Topical application of subgingival hyaluronic acid gel can be used as an 
adjunct to scaling and root planing. 
 Bone regeneration in periodontal bony defects. 
 Guided Bone Regeneration. 
 In non surgical therapy of peri-implant pockets. 
 Peri-implant maintenance of immediate function implants. 
 As autologous cell hyaluronic acid graft gingival augmentation in 
mucogingival surgery. 
 As a carrier for newer molecules in various regenerative procedures. 
 As a biomaterial scaffold in tissue engineering research. 
 
CLINICAL STUDIES 
Clinical studies done by Sasaki T and Kawamata-Kido H 1995, have shown 
osteoinductive property of hyaluronan. It stimulates the osteoprogenitor cells from the 
defect which undergo successive differentiation into osteoblasts, resulting in 
formation of new bone
72
.  
Pirnazar P et al., 1999, suggested that the clinical application of hyaluronic 
membrane, gels or sponges during surgical therapy reduces bacterial contamination of 
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surgical wound site, thereby, lessening the risk of postsurgical infection and 
promoting more predictable regeneration
70
.  
According to Hunt DR et al., 2001, hyaluronan is thought to be the best carrier for 
the Bone Morphogenic Proteins (BMP), the growth factors commonly documented to 
stimulate the formation of new bone tissue
73
.  
Pistorius Alixander et al., 2005, evaluated the efficacy of topical application of HA 
for treatment of gingivitis and found that topical application of HA containing 
preparation was potentially useful adjunct in the therapy of gingivitis
74
. 
Gengigel
®
 (Ricerfarma s.r.l, Milano, Italy) is a topically applied anti-inflammatory 
product that has been specifically developed for dental use. It contains high molecular 
weight fractions of hyaluronic acid in gel formulation with 0.2% concentration. 
According to Koshal A et al., 2007, the adjunctive use of Gengigel
®
 after thorough 
mechanical debridement has major clinical benefits in terms of improved healing after 
non-surgical therapy and demonstrates significant improvements in bleeding on 
probing and pocket depth measurements
75
.  
M de Arau’jo Nobre et al., in 2007, during the course of their study found that HA 
and chlorhexidine produced good results in maintaining a healthy peri-implant 
complex in immediate function implants for complete rehabilitations in the edentulous 
mandible. Statistically, significant differences were found in favour of the HA group 
in the modified bleeding index 
76
. 
Hyaloss
®
 matrix (ester of hyaluronic acid with benzyl alcohol (HYAFF™) was used 
for the correction of infrabony defects and it was concluded that autologous bone 
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combined with an esterified low-molecular HA preparation has good capabilities in 
accelerating new bone formation in the infra-bone defects (Ballini A et al., 2009)
77
.  
Vanden Bogaerde L. 2009, treated periodontal intra-bony defects with esterified 
hyaluronic acid. A full-thickness flap was raised and the roots were accurately planed; 
hyaluronic acid in the form of fibers was then packed into the defect to completely fill 
the space. One year after treatment, the mean PPD was reduced by 5.8 mm (range, 0 
to 10 mm), gingival recession had increased by 2.0 mm (range, 0 to 6 mm), and 
attachment gain was 3.8 mm (range, 0 to 7 mm)
78
. 
Nadiger S and Kharidi VL 2011, observed anti-inflammatory effects of 0.2% 
hyaluronic acid for treating gingivitis. The authors concluded that, HA was an 
effective topical agent for treating gingivitis, along with scaling and intrasulcular 
application
79
.  
Pilloni et al., 2011, in their randomized controlled clinical pilot study, evaluated the 
efficacy of an esterified form of HA gel on periodontal clinical parameters. The 
periodontal clinical parameters were plaque index (PI), BOP, PPD, gingival index 
(GI), and probing attachment level. In the end of the study, they concluded that an 
esterified gel form of HA has shown an effect in reducing the gingival inflammation 
when used as an adjunct to mechanical home plaque control and that it could be 
successfully used to improve the periodontal clinical indexes
80
. 
The use of Gengigel
®
 in addition to SRP for local subgingival treatment has been 
investigated clinically as well as histologically by Gontiya G, Galgali S in 2012. 
They observed a significant improvement in gingival parameters but periodontal 
factors remained unchanged
81
. 
Review of Literature 
 
29 
 
Fawzy El‑Sayed et al., 2012, in a randomized controlled trial evaluated the effect of 
local application of 0.8% Hyaluronan gel in conjunction with periodontal surgery and 
noted statistically significant differences in clinical attachment level (P < 0.05) in 
favour of the test sites though non-significant results were obtained regarding probing 
depth
82
. 
 Sahayata Vishal N et al., 2014, evaluated the use of 0.2% hyaluronic acid gel 
(Gengigel
®
) in the treatment of gingivitis clinically and microbiologically. The 
authors concluded that adjunctive use of 0.2% HA gel provided statistically 
significant results. it was safe, very well tolerated and well accepted by patients and 
could reduce the tendency to relapse in patients with plaque induced gingivitis. 
However, it has very limited antimicrobial effect
83
. 
Radhika Kumar et al., in 2014, assessed the efficacy of hyaluronic acid (HA) in root 
coverage procedures as an adjunct to coronally advanced flap (CAF) procedure. 
Though, there was no statistically significant difference, root coverage in the 
experimental group appeared to be clinically more stable compared with the control 
group after 24 weeks. The study concluded that the use of HA may improve the 
clinical outcome of root coverage with CAF procedure
84
. 
The combination of 0.2% hyaluronic acid gel with Platelet-Rich Fibrin (PRF) was 
reported by Sandhu et al., for the treatment of Grade II furcation. Similarly, Kalra, 
et al., reported the use of 0.2% hyaluronic acid gel in conjunction with amnion 
membrane in Grade II furcation defect. 
Sandhu GK et al., 2015 reported the regenerative capacity of HA gel (Gengigel
®
) in 
conjunction with PRF in a patient with Grade II furcation defect, through surgical 
re‑entry after 6 months. The furcation area was reassessed clinically with the help of 
Review of Literature 
 
30 
 
Q2N Naber’s probe to assess the bone fill. Healing was uneventful and at 6 months of 
follow‑up, there was substantial defect fill in the furcation area with a residual 
horizontal dimension of <1 mm at 6 months, representing a significant percentage of 
bone formation. Hence it was observed that the combined approach resulted in 
significant furcation defect fill on re‑evaluation at 6 months85. 
Kalra et al., in 2015 reported the radiographic assessment of the regenerative 
capacity of HA gel (Gengigel
®
) in conjunction with bioactive amnion GTR membrane 
in a patient with Grade II furcation defect. Roentgenographic assessment was done at 
4 months and 6 months postoperatively. It resulted in complete defect fill and loss of 
radiolucency at 6 months. The authors stated that the surgical placement of HA gel 
along with amnion membrane in the furcation defect can significantly improve the 
periodontal defect morphology
86
. 
Batavia PD et al., 2016 compared the effects of hyaluronan (Gengigel
®
) alone and in 
combination with scaling using clinical, microbial, and lactate dehydrogenase (LDH) 
parameters. They concluded that the clinical, microbial, and biochemical parameters 
reported with the different treatment modalities clearly support the use of Gengigel as 
an advantageous adjunct to scaling. Further studies are required to confirm the effects 
of HA gel using histologic methods
87
. 
Sugandha Gupta et al., 2017, evaluated the role of Gengigel
®
 (0.8% hyaluronic 
acid) as a potential material for regeneration of lost attachment apparatus. A total of 
20 sites with Grade II furcation defects from 10 patients were selected using random 
sampling technique. These were divided into Group A (placement of hyaluronic acid) 
and Group B (without placement of hyaluronic acid) according to treatment modality. 
Furcation defect assessment was done in vertical and horizontal depth preoperatively 
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and postoperatively at six months through surgical re-entry. The results showed that 
mean plaque index, gingival index and bleeding index score were statistically 
significant for both the groups at baseline and six months. Mean difference in probing 
pocket depth and Relative Attachment Level (RAL) were statistically highly 
significant, whereas, mean difference of gingival position margin was not significant 
for both the groups, at baseline and six months. Mean difference in horizontal 
component at baseline and six months was statistically highly significant for both the 
groups. Mean difference in vertical component at baseline and six months was 
statistically significant for both the groups. On comparison, the mean difference in 
vertical and horizontal component of Group A and Group B at six months was 
statistically not significant. It was concluded that both Gengigel
®
 with coronally 
positioned flap and coronally positioned flap alone were effective in the treatment of 
Grade II furcation defects. The combination of Gengigel
®
 with coronally positioned 
flap leads to better results in hard tissue measurement as compared to coronally 
positioned flap alone
88
. 
 
Based on the available literature supporting the beneficial effects of chorion GTR 
membrane and 0.2% hyaluronic acid gel for regeneration, this study was done with 
combination of 0.2% hyaluronic acid gel with chorion membrane in Grade II 
furcation defects.  
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MATERIALS AND METHODS 
SOURCE OF DATA 
The study population was selected from the Outpatient Section of the Department of 
Periodontics, Tamilnadu Government Dental College and Hospital, Chennai, India. 
INCLUSION CRITERIA 
1. Teeth selection: Mandibular permanent first molars  
2. The sites should exhibit clinical and radiographic evidence of Grade II 
furcation defects (Horizontal probing depth of ≥3mm, Interproximal probing 
depth ≥ 5mm). 
3. Age between 20 and 50 years  
4. Systemically healthy patients  
5. Patients with established willingness and ability to perform adequate oral 
hygiene. 
 
EXCLUSION CRITERIA 
1. Subjects who have received periodontal flap/regenerative therapy within the 
past 1 year  
2. Patients who have received antibiotic therapy within the past six months 
3. Pregnant and lactating patients 
4. Smokers   
5. Patients who demonstrate poor oral hygiene maintenance after Phase I therapy. 
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6. Tooth with gingival recession, endodontic-pulpal involvement, or mobility > 
Grade II. 
7. Systemic illness known to affect the outcomes of periodontal therapy; such  as  
diabetes  mellitus, cardiac diseases, immune-compromised (e.g. HIV 
individuals, under radiotherapy) , patients  taking  medications  such as  
corticosteroids  or  calcium  channel  blockers, which are known to interfere 
with periodontal wound healing. 
8. Patients with any known allergy to drugs 
 
STUDY DESIGN 
All the ethical principles were meticulously followed throughout the course of the 
study. Subjects were selected randomly. After explaining the study procedure 
(Annexures 1,2), written informed consent (Annexures 3,4) was obtained from all 
the subjects selected for the study. Examination (Annexures 5) was preceded by a 
thorough medical and dental history of the subjects. Each subject underwent full-
mouth periodontal probing and charting, and radiographic evaluation. 
 
SUBJECTS 
A total of 10 patients with clinical and radiographic evidence of Grade II furcation 
involvement, indicated for regenerative periodontal surgery were selected randomly. 
 
STUDY PROTOCOL:  
1. Patient selection as per the inclusion & exclusion criteria.  
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2. Medical history and informed consent.  
3. Complete periodontal examination using a mouth mirror and William’s & Naber’s 
periodontal probe under artificial light  
4. Intra-oral evaluation and periodontal examination - Clinical periodontal parameters 
namely, Plaque index, Gingival Bleeding Index, Probing Pocket Depth, Horizontal 
Probing Depth and Clinical Attachment Level  
5. Radiographic evaluation- Orthopantamogram, Intraoral periapical radiograph 
6.Phase I therapy and re-evaluation of clinical parameters after 4 weeks.  
7.Surgical procedure- Regenerative therapy with 0.2% hyaluronic acid gel application 
and chorion GTR membrane placement in the defect site 
8. Post-operative care.  
9. Clinical and Radiographic re-evaluations at the end of 3 and 6 months.  
 
PRE-OPERATIVE CLINICAL ASSESSMENT 
CLINICAL PARAMETERS 
The clinical parameters evaluated at baseline and post surgically at 3
 
and 6
 
months 
were: 
1. Plaque index (PI) 
2. Gingival bleeding index (GBI)
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3. Probing Pocket Depth (PPD): Measured with customized acrylic stent and UNC-15 
probe.
 
4. Horizontal probing depth (HPD) at furcation level: Measured with Naber’s probe 
5. Clinical attachment level (CAL)  
Plaque Index (Silness and Loe 1964)
89
 
All teeth were examined at 4 sites each (disto-facial, facial, mesio-facial lingual / 
palatal) and were scored as follows :  
Criteria for Scoring:  
Score 0 : No plaque  
Score 1: Plaque not visible to the naked eye, detected only by running the explorer or 
by using a disclosing agent  
Score 2: Thin to moderate accumulation of soft deposits within the gingival pocket or 
on tooth and gingival margin, visible to the naked eye 
 Score 3: Abundance of soft matter within gingival pocket and/or on tooth surface and 
margin, inter-dental area stuffed with soft debris  
Calculation:  
Plaque index per tooth = Total score / 4 
Plaque index per individual = 
Total  PI  per  tooth
Total  number  of  teeth  examined
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Interpretation:  
 
 
 
 
 
Gingival Bleeding Index (Ainamo & Bay 1975)
90 
Starting distobuccally, the probe was inserted slightly into the sulcus and run to the 
buccal and mesial surfaces of every tooth at an angle of about 45°. This was repeated 
for all teeth present. Probing was similarly carried out at palatal/lingual sites. Any 
gingival units that exhibited bleeding were recorded. The total number of bleeding 
sites per tooth was thus recorded for every tooth except the third molar.  
Criteria for Scoring  
Positive score (1) - Presence of bleeding within 30 seconds  
Negative score (0) - Absence of bleeding 
 % of bleeding sites = 
Total  number  of  positive  score  x 100 
Total  number  of  surfaces  of  all  teeth
 
Stent Preparation  
Acrylic occlusal stents were fabricated over the study models. Self cure acrylic was 
used for this purpose. The stent covered the occlusal and coronal 1/ 3rd of the labial 
Score 0 Excellent oral hygiene 
0.1 to 0.9 Good oral hygiene 
1.0 to 1.9 Fair oral hygiene 
2.0 to 3.0 Poor oral hygiene 
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and lingual surfaces of the teeth. Vertical grooves were made to guide the placement 
of the probe in the same plane and direction repeatedly during measurements to avoid 
any variation. The recordings were made using a UNC 15 periodontal probe. 
Probing Pocket Depth  
A customized acrylic stent was prepared and stored in the cast itself. The base of the 
stent served as a reference point (RP) to take the measurements.  Probing depth was 
calculated by measuring the distance from a fixed reference point on the stent to the 
base of the pocket (BP) along the groove using a UNC-15 periodontal probe and 
subtracting it by the distance from the fixed reference point to the gingival margin 
(GM). 
 
RADIOGRAPHIC PARAMETERS 
Intraoral periapical radiographs were taken with radiographic grid for each site using 
long cone paralleling technique and XCP holders at baseline and post surgically at 3 
and 6 months.  
All radiographs were digitalized using digital camera and transferred to the computer 
as JPEG image. To measure the linear radiographic defect depth (DD) in millimetre 
(mm), ImageJ software designed for image analysis by National Institute of Health 
(NIH) was used.  
The following anatomical landmarks of the intrabony defect were identified on the 
radiograph images based on criteria set by Bjorn et al
91
 and by Schei et al
92
.  
1. CEJ: The cemento-enamel junction of the tooth with the intrabony defect.  
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2. AC: Most coronal position of the alveolar bone crest of the intrabony defect when it 
touches the root surface of the adjacent tooth before treatment, the top of the crest.  
3. BD: The most apical extension of the intrabony destruction where the periodontal 
ligament space still retained its normal width before treatment, the bottom of the 
defect.  
If restorations were present, the apical margin of the restoration was used to replace 
the CEJ as a fixed reference point. 
The following linear measurements were performed
93
:  
1. CEJ to bottom of the defect (CEJ to BD)  
2. CEJ to furcation fornix (CEJ TO FX) 
Depth of the furcation defect at baseline = (CEJ to BD) - (CEJ to FX)  
Correction factor: In order to estimate distortion between the consequent 
radiographs, an anatomically non-variable distance i.e. the root length (distance from 
the CEJ to the root apex (CEJ to RA) was measured on all the radiographs.  
The correction factor (CF) was calculated as follows:  
CEJ  to  RA  baseline  
CEJ  to  RA   post −op  
 = CORRECTION FACTOR 
In this study the measurement between CEJ- FX was taken for calculation of 
correction factor  
Defect fill (DF) = [FX to BD (baseline)] - [FX to BD (post op) x CF]  
 Defect fill percentage (DF %) = [defect fill/defect depth (baseline)] x 100 
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ARMAMENTARIUM 
1. Mouth mirror  
2. UNC 15 probe 
3. Nabers probe 
4. Explorer  
5. Tweezers 
6. Kidney tray 
7. Sterile Cotton roll 
8. Disposable gloves, head cap, facemask 
9. Customized  acrylic  stents   
10. IOPA film 
11. Radiographic grid. 
12. Ultrasonic scaler 
13. Local anaesthetia-2% Lignocaine HCl with adrenaline (1:80,000) 
14. Disposable syringes and needles  
15. Standard set of Gracey Currettes 
16. Sterile gauze pieces 
17. Suction tips 
18. Sterile surgical gloves 
19. Bard Parker handles No 3 
20. Bard Parker Blade Nos.12 and 15 
21. Periosteal elevator 
22. Cumine scaler 
23. A pair of curved and straight scissors 
24. Chorion membrane ( Tata Memorial Hospital -Tissue Bank , Mumbai ) 
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25. 0.2% hyaluronic acid gel - Gengigel® (Ricerfarma, Milano, Italy) 
26. Disposable blunt cannula tip 
27. Normal saline 
28. Needle holder 
29. Tissue holding forceps 
30. Suture (3-0, non-resorbable black threaded silk) 
31. Glass slab, mixing spatula 
32. Non-eugenol periodontal dressing (Coe-Pak™) 
 
SURGICAL PROCEDURE 
Extra oral antisepsis and intra oral antisepsis were performed with 5% povidone 
iodine solution and 0.2% chlorhexidine digluconate mouthrinse respectively. The 
operative site was anaesthetized with 2% Lignocaine HCl with adrenaline (1:80,000) 
using block and infiltration techniques, following which an intrasulcular incision was 
made around the involved tooth and extending to the adjacent tooth for adequate 
access. Full thickness mucoperiosteal flap was reflected to access the underlying bone 
morphology in the furcation area. After thorough debridement, the furcation area was 
assessed using Naber’s probe. The area was properly debrided using Gracey curettes. 
Saline irrigation was done and pre-suturing of the flap was done with 3-0 silk suture. 
Following this, 0.2% hyaluronic acid gel was applied into the furcation area (slightly 
overfilled). The processed freeze dried and dehydrated chorion was placed as a GTR 
membrane on the furcation area and proximal bone. Upon placement, the dehydrated 
chorion membrane became hydrated and self‑adhered to the area, eliminating the need 
for suturing. The pre-sutured flap was repositioned over the chorion membrane and 
secured with interrupted direct loop 3-0 non-resorbable silk sutures, periodontal 
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dressing was placed. All patients were prescribed systemic antibiotics (Amoxycillin 
500mg thrice daily, Metronidazole 400mg twice daily) and analgesics (Ibuprofen 
400mg thrice daily) for 1 week. Periodontal dressings and sutures were removed 7-10 
days after surgery 
 
POST OPERATIVE INSTRUCTIONS 
1. A periodontal pack was placed over the surgical site to protect it from 
irritation. It hardened in few hours and remained in place until next recall visit. 
2. If a piece of pack breaks off or if rough edges started irritating patient’s tongue 
or cheek, he/ she was advised to report to the hospital immediately. 
3. Patients were advised to avoid hot and hard food for the first 24 hours at the 
operated site. 
4. During the first day, patients were advised to apply ice pack intermittently on 
face over the operated area. 
5. Patients were instructed to continue regular home hygiene care, except in the 
operated area, in which tooth brushing was discontinued for 7 days after 
surgery and plaque control was maintained by means of gentle topical 
applications of chlorhexidine gluconate in saturated cotton swabs twice a day.  
6. Gentle tooth brushing with an extra soft‑bristle toothbrush using Charter’s 
method was initiated. 
 
POST SURGICAL EVALUATION AND REVIEW 
1. Post surgical evaluation was done at 1 week, 3 months and 6 months. 
2. Intraoral periapical radiographs were taken using long cone paralleling 
technique, with grid in position at 3 and 6 months to evaluate the bone fill. 
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3. Probing Pocket Depth, Clinical Attachment Levels and Horizontal Probing 
Depth were reassessed with the previously used acrylic stents during the post 
surgical evaluation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
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PHOTOGRAPHS 
 
 
Photograph 1: Surgical Armamentarium 
 
 
Photograph 2: XCP Holders with Radiographic grid 
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Photograph 3: 0.2% Hyaluronic Acid Gel (Gengigel
®
, Ricerfarma, Milano, Italy) 
Chorion Membrane (Tissue Bank, Tata Memorial Hospital, Mumbai) 
 
 
 
Photograph 4: Radiographic Landmarks 
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PRE-OPERATIVE VIEW  
 
Photograph 5: Pre-operative Probing Pocket Depth 
 
 
Photograph 6: Pre-operative Horizontal Probing Depth 
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INTRA-OPERATIVE VIEW 
 
Photograph 7: Defect after debridement and degranulation 
 
  
 
 
 
Photograph 8: Grade II Furcation Defect  
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Photograph 9: Pre-suturing of the flap; Application of 0.2% Hyaluronic Acid 
Gel into the defect 
 
Photograph 10: Insertion of Chorion Membrane; Self-Adhesion and Adaptation 
of the membrane over the defect 
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Photograph 11: Re-approximation of flaps with silk suture 
 
 
Photograph 12: Periodontal dressing (Coe-pack) placed over the surgical site 
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POST- OPERATIVE VIEW 
 
Photograph 13: Post-operative Soft tissue healing at 6 months 
 
 Photograph 14: Probing Pocket Depth at 3 months  
 
Photograph 15: Probing Pocket Depth at 6 months 
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Photograph 16: Horizontal Probing Depth at 3 months 
 
 
Photograph 17: Horizontal Probing Depth at 6 months 
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Photograph 18: Pre-operative IOPA  
 
Photograph 19: Post-operative IOPA at 3 months 
 
Photograph 20: Post-operative IOPA at 6 months 
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                             Analysis of radiographic image with ImageJ Software 
 
Photograph 21: Setting scale of 1 mm per radiographic grid 
 
 
Photograph 22: Measurement of defect 
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STATISTICAL ANALYSIS 
 The statistical analysis was done using the computer software program SPSS version 
16 (IBM CORP, CHICAGO, IL, USA). Descriptive data are presented as mean ± SD 
and range values. 
Data of parameters Plaque Index (PI), Gingival Bleeding Index (GBI), Probing Pocket 
Depth (PPD), Horizontal Probing Depth (HPD), Clinical Attachment Level (CAL) 
and Defect Depth (DD) at baseline, 3 months, and 6 months were assessed. The 
intragroup comparison was done by repeated measures ANOVA test. The paired t test 
was used for bone fill (BF), and bone fill percentage (BF %). 
 p value  
The p value or calculated probability was the estimated probability of rejecting the 
null hypothesis (H0) of a study question when that hypothesis was true. The smaller 
the p-value, the more significant the result was said to be. Confidence intervals were 
calculated at the 95% level. Differences between the two time intervals were 
considered significant when p ≤ 0.05. 
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STATISTICAL FORMULAE USED FOR DATA ANALYSIS 
 
Repeated measures ANOVA: 
 
 
Paired sample t test for 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
                                                                     
 
 
 
 
 
 
 
 
 
            Results 
--------------------------------------------------------------------------------------------------------- 
 
 
Results 
 
55 
 
RESULTS 
Analysis of clinical parameters 
Plaque index: 
The mean plaque score at baseline was 2.01±0.34 and 1.05±0.27 at 3 months. The mean 
reduction was 0.96±0.09 which was found to be highly significant (p= 0.000). At 6 months, 
the mean plaque score was 0.51±0.15. The mean reduction was 0.54±0.79 and 1.5±0.1 
between 3 - 6 months and baseline - 6 months respectively, both of which were statistically 
highly significant (p= 0.000). 
Gingival bleeding index: 
The mean GBI scores were 61.95±15.98, 32.84±12.7, 11.10±2.37 at baseline, 3 months and 6 
months respectively. The mean reduction between baseline and 3 months was 29.1±3.52, 
between 3- 6 months was 21.7±3.58, and between baseline and 6 months was 50.85±4.49. All 
values were statistically highly significant with p= 0.000. 
Probing Pocket Depth 
The mean probing depth at baseline was 7.0±0.94 as compared to 3.9±0.56 at 3 months. The 
mean reduction was 3.1±0.27 which was highly significant (p=0.000). The mean PPD at 6 
months was 1.8±0.63 with a reduction of 2.1±0.18 as compared to 3 months and 5.2±0.24 as 
compared to baseline. Both the values were highly significant statistically (p=0.000). 
Clinical Attachment level 
The baseline CAL had a mean value of 7.0±0.94 as compared to 4.1±0.73 at 3 months and 
2.1±0.73 at 6 months. The mean reduction between baseline CAL and 3 months was 2.9±0.23 
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(p= 0.000), between 3 and 6 months was 2.0±0.25 (p= 0.000), between baseline and 6 months 
was 4.9±0.27 (p= 0.000). All values were statistically highly significant at all time intervals. 
Horizontal Probing depth 
The mean HPD at baseline was 4.9±0.87, at 3 months it was 2.4±0.69 and at 6 months it was 
0.7±0.67. The mean reduction between between baseline and 3 months was 2.5±0.22 which 
was highly significant (p=0.000). The mean reduction between 3 and 6 months was 1.7±0.3 
and was statistically significant (p=0.001). Between baseline 6 months the mean reduction 
was 4.2±0.24 and was highly significant statistically (p=0.000).  
Analysis of radiographic parameters 
Defect Depth 
The mean defect depth was 2.97±0.32 at baseline, 1.88±0.35 at 3 months and 0.36±0.18 at 6 
months. The mean reduction was 1.09±0.08 between baseline and 3 months, 1.52±0.08 
between 3 and 6 months and 2.61±0.08 between baseline and 6 months. All the values were 
highly significant statistically (p=0.000). 
Bone fill  
The mean bone fill in mm at 3 months was 1.19±0.45 and at 6 months was 2.7±0.33. Paired t 
test revealed a mean difference of 1.51±0.45 which was highly significant statistically 
(p=0.000).  
The mean bone fill % at 3 months was 40.73±14.98 and at 6 months was 91.2±6.11. Paired t 
test revealed a mean difference of 50.47±14 which was highly significant statistically 
(p=0.000). 
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DISCUSSION 
Hyaluronic acid, an integral part of the extracellular matrix, has been advocated for 
periodontal regeneration and healing.  Hyaluronan interacts with fibrin clot and 
provides a structural framework to enable ECM cell infiltration into the inflamed site. 
It helps in organisation of granulation tissue by promoting proliferation and migration 
of matrix cells. Hakansson et al., suggested the role of hyaluronan in migration and 
adherence of neutrophils and macrophages at the inflamed site and the resultant 
phagocytosis and destruction of invading pathogens
94
. They also promote 
angiogenesis and enhance bone formation by their osteoconductive nature. Similarly, 
chorion GTR membrane used in this study has a rich source of growth factors, various 
collagen types, and cell-adhesion bioactive factors, such as fibronectin and laminin. 
The tissue grafts of placental membrane are unique biomaterials as they present a low 
risk of immune rejection and are rightly termed as“immune privileged”. They act as 
a native scaffold for wound healing and promote regeneration. The abundant 
concentrations of laminin and laminin-5 throughout the barrier have high affinity for 
binding gingival epithelial cells and may contribute for their better adaptation to the 
root surface (Pakkala et al., 2002)
95
. Their self adherent nature eliminates the need 
for suturing the membrane, making the procedure less demanding and time saving. 
The present study was designed to evaluate the regenerative efficacy of 0.2% 
hyaluronic acid gel in conjunction with chorion membrane in Grade II furcation 
defects. A total of 10 subjects were included in the study, 5 male and 5 female. The 
clinical and radiographic parameters were recorded at baseline, 3months, and 6 
months. Highly significant improvements were obtained in mean PI (0.51±0.15), GBI 
(11.10±2.37), PPD (1.8±0.63) and CAL (2.1±0.7) at 6 months (p = 0.000). These 
Discussion 
 
67 
 
results were similar to those obtained by Shaila V. Kothiwale, 2013
50 
using chorion 
membrane in intra-bony defects, where the PI, GI, PPD and CAL showed significant 
improvements at 12 months. As we dealt with furcation defects, HPD was also 
included in the clinical parameters and showed highly significant improvements from 
baseline 4.9±0.87 to 6 months 0.7±0.67 (p = 0.000). The reduction in the above 
parameters can be attributed to the thorough debridement and eradication of 
periodontal pockets. The advantage of using bioabsorbable chorion membrane is that 
it eliminates the need for a second surgical procedure, enabling the clinical results to 
improve without disrupting the bone fill or attachment gain. Apart from this, the 
presence of Tissue Inhibitor Of Metalloproteinases (TIMPs) in CM, suppresses matrix 
metalloproteinases (MMPs) and the transforming growth factor beta (TGF-β) 
abundant in CM, stimulates the production of TIMPs from the surrounding tissue 
(Hao et al.,2000
96 
; Riau et al.,2010
97
). At 6 months, the PI and GBI scores decreased 
from baseline values of 2.01±0.34, 61.95±15.98 to 0.51±0.15, 11.10±2.37 
respectively, indicating good oral hygiene maintenance by the patients.  
The mean furcation defect depth (DD) at baseline was 2.97±0.32 which eventually 
subsided to 1.88±0.35 at 3 months and 0.36±0.18 at 6 months. The radiographic 
parameters showed mean BF of 1.19±0.45 and 2.7±0.33 at 3 and 6 months 
respectively. The statistical analysis revealed highly significant bone fill at 3 and 6 
months (p=0.000). Similar results were obtained by Shaila V. Kothiwale 2013,
50
 
where, at 6 months the mean of the bone gain (BG) was 0.86 ± 0.18 and at 12 months 
the mean of the BG was 1.22 ± 0.35 (p= 0.0382) with a significant bone fill from 
baseline to 12 months.   
Sugandha Gupta et al., 2017,
88
 used hyaluronic acid (Gengigel®) for regeneration in 
Grade II furcation defects with coronally advanced flap and assessed the sites through 
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surgical re-entry. The authors reported statistically significant mean differences in 
bone fill in both the horizontal (1.44±0.72) and vertical (0.44±0.52) components 
between baseline and 6 months. It was concluded that the additional use of Gengigel® 
leads to better results in hard tissue measurement. Sandhu GK et al., 2015,
85 
Kalra 
SH et al., 2015,
86 
assessed the use of 
 
Gengigel® in Grade II furcation defects. The 
former authors reported that the surgical re-entry at 6 months revealed a residual 
horizontal dimension of <1 mm. The latter authors observed a significant percentage 
of bone formation in furcation area radiographically and stated a significant 
improvement in defect fill.  
In accordance with the above results, the present study also showed highly significant 
improvements in terms of PI, GBI, PPD, CAL, HPD, and BF between baseline and 6 
months. Moreover, the combined use of 0.2% hyaluronic acid gel with chorion 
membrane resulted in a bone fill percentage as much as 91.2±6.11 at 6 months, which 
indicates a near complete closure of furcation defects, paving way for the long term 
maintenance of periodontal health. 
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SUMMARY AND CONCLUSION 
Success of periodontal therapy in the furcation region poses a great challenge to 
clinicians. Regenerative therapies have been advocated for furcation defect 
management depending on the extent of furcal bone loss, where Grade II defects are 
considered to have predictable outcome (Avila-Ortiz et al 2015)
22
. The most 
desirable outcome of regenerative therapy is the closure of the furcation defects and to 
attain this, numerous materials have evolved. The combined use of two novel 
biomaterials, 0.2% hyaluronic acid gel and chorion membrane in the management of 
Grade II furcation defects, was evaluated clinically and radiographically at baseline, 
3months and 6 months intervals and the following conclusions could be drawn: 
1. The combined use of 0.2% hyaluronic acid gel with chorion membrane can be 
considered a successful and predictable treatment option for Grade II furcation 
defects. 
2. The treatment resulted in statistically highly significant improvements in plaque 
scores, bleeding on probing indices, reduction in pocket probing depth, horizontal 
probing depth and gain in clinical attachment levels. 
3. Based on the radiographic findings, the mean bone fill (in mm) was 1.19±0.45 at 3 
months and 2.7±0.33 at 6months, accounting to a mean bone fill percentage of   
40.73±14.98 at 3 months and 91.2±6.11 at 6 months. The values were highly 
significant statistically (p=0.000). This near complete closure of the defects achieved, 
predicts the effectiveness of 0.2% hyaluronic acid gel in conjunction with chorion 
membrane in the regeneration of Grade II furcation defects.  
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Within the limitations of this study, it could be concluded that the combined use of 
0.2% hyaluronic acid gel and chorion GTR membrane resulted in highly significant 
improvements in all the clinical and radiographic parameters evaluated at all time 
intervals. However, controlled clinical trials are required with larger sample size and 
long-term follow-up to validate the regenerative capabilities of these materials where, 
histologic evaluation and surgical re-entry would be more appropriate methods to 
confirm the findings.  
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ANNEXURE-1 
PARTICIPANT INFORMATION SHEET 
 
Investigator : DR.AKSHAYA  NARAYANAN    
Guide          : DR.JAISHREE TUKARAM KSHIRSAGAR, MDS 
Title : EVALUATION  OF REGENERATIVE EFFICACY OF 0.2% HYALURONIC ACID GEL IN 
CONJUNCTION WITH CHORION MEMBRANE IN GRADE II FURCATION DEFECT – A 
CLINICAL  STUDY 
Name of the research institution : Tamilnadu Government Dental College and Hospital, Chennai 
The investigator, Dr. AKSHAYA NARAYANAN under the guidance of Dr. JAISHREE                      
TUKARAM KSHIRSAGAR, MDS is conducting a study as titled above with aim to do an evaluation of 
efficacy of 0.2% hyaluronic acid gel  in conjunction with chorion membrane in grade II furcation defect. 
1. Procedure : the following examinations and investigations will be done for you. 
 Intraoral examination, Extraoral examination 
 Blood test –  7ml of blood will be drawn from your hand 
 X-ray will be taken for the diseased site with protection (lead apron , thyroid collars ) 
 Model of your teeth will be prepared by taking alginate impression 
 Deposits on your teeth will be cleaned with ultrasonic scaler and hand instrument. Surgery 
will be done with placement of intended material in the diseased site  
 Clinical and radiological evaluation will be performed at baseline , 3 months and 6 months 
after the procedure.  
2. Risk of  participation: 
 Patients may be allergic to LA or the material used in the study. 
 Patient may experience pain, discomfort, swelling following the procedure. 
3. Benefits of participation:  
Patients will be treated for improving the periodontal status and minimizing alveolar bone loss. 
4. Confidentiality : 
The identity of the patients participating in the research will be kept confidential throughout 
the study. In the event of any publication or presentation resulting from the research, no 
personally identifiable information will be shared. 
5. Participants right : 
Taking part in the study is voluntary. You are free to decide whether to participate in the study 
or to withdraw at any time; your decision will not result in any loss of benefits to which you are 
otherwise entitled. The results of this study will be intimated to you at the end of the study period or 
during the study if anything is found abnormal which may aid in the management or treatment. 
6. Compensation: Nil 
7. Contacts:  
 
For queries related to the study: 
Primary Investigator:  
Dr.Akshaya  Narayanan 
PG Student 
Department of Periodontics 
Tamilnadu Govt. Dental College & Hospital 
Chennai- 600 003       Mobile - 9003183857 
Contact details regarding rights of the 
participant: 
Dr. B. Saravanan, MDS,PhD, 
The Chairperson, 
Institutional Ethical committee 
Tamilnadu Govt. Dental College & Hospital, 
Chennai-600 003. 
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 ஆபாய்ச்சி மநற்க ாள்஧யர்:நரு.அக்ஷனா ஥ாபானணன்  
 யமி஥டத்து஧யர்          :நரு.கெய்ஸ்ரீ து ாபாம் க்ஷிர்சா ர்,MDS 
 
 
 
 
 
  
இ஭ண்டாம் த஭ பல் வேர் பிரிவு பகுதி எலும்பு வதய்஫ானத்தில் 0.2% ஹை஬லூவ஭ானிக் அ஫ியம் 
அஹ஭த்தின்஫க் கஹ஭சல் உடன் வேரிச் சிஹனக்கருச் சவ்வு இஹைத்து ப஬ன்படுத்தி ஫ீல௃ருோக்கம் 
திமன் ஫திப்பீடு – ஒரு ஫ருத்துே ஆய்வு 
 
 
 
 
இபண்டாம் தப ஧ல் மயர் ஧ிரிவு ஧குதி எலும்பு மதய்நா஦த்தில் 0.2% ஹைனலூமபா஦ிக் அநி஬ம் 
அஹபத்தின்நக்  ஹபசல் உடன் கய஭ிச் சிஹ஦க் ருச் சவ்வு இஹணத்து ஧னன்஧டுத்தி நருத்துய நற்றும் 
 திரினக்  நதிப்஧டீு ஹ஭ அறுஹய சி ிச்ஹசக்கு முன் ,3 நாதங் ள்ல௃க்கு ஧ின் நற்றும் 6 
நாதங் ள்ல௃க்கு ஧ின் ஆய்வு கசய்தல் 
 
 
 
 
 
 0.2% ஹைனலூமபா஦ிக் அநி஬ம் அஹபத்தின்நக்  ஹபசல் உடன் கய஭ிச் சிஹ஦க் ருச் சவ்வு 
இஹணத்து இபண்டாம் தப மயர் ஧ிரிவு ஧குதி எலும்பு மதய்நா஦த்தில் ஧னன்஧டுத்தப்஧டும் 
 நருத்துய நற்றும்  திரினக்  நதிப்஧டீு கதாடக்  ஥ிஹ஬னில், 3 நாதங் ள்ல௃க்கு ஧ின் நற்றும் 6 
நாதங் ள்ல௃க்கு ஧ின் கசய்னப்஧டும் 
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ஆபாய்ச்சி மநற்க ாள்஧யர்: 
நரு.அக்ஷனா ஥ாபானணன் 
முது ஹ஬ நாணயி   
தநிம  அபசு ஧ல் 
நருத்துயக்  ல்லூரி நற்றும் 
நருத்துயநஹ஦ 
கசன்ஹ஦- 600003 
கதாடர்பு எண்: 9003183857 
நரு.஧ி. சபயணன் MDS, PhD
தஹ஬யர் , 
஥ிறுய஦ க஥஫ிமுஹ஫ ள் குழு 
தநிம  அபசு ஧ல் நருத்துயக் ல்லூரி 
நற்றும் நருத்துயநஹ஦ 
கசன்ஹ஦- 600003 
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ANNEXURE-3 
 
INFORMED CONSENT FORM 
 
EVALUATION  OF REGENERATIVE EFFICACY OF 0.2% HYALURONIC ACID 
GEL IN CONJUNCTION WITH CHORION MEMBRANE IN GRADE II 
FURCATION DEFECT – A CLINICAL STUDY 
 
Participant ID No: 
 
“I have read the foregoing information, or it has been read to me. I have had the 
opportunity to ask questions about it and any questions I have asked have been 
answered to my satisfaction. I consent voluntarily to participate as a participant in this 
study and understand that I have the right to withdraw from the study at any time 
without in any way it affecting my further medical care.” 
 
 
_______________               _________________                  __________________ 
Date                                          Name of the participant            Signature/thumb impression     
                                                                                                             Of the participant   
 
 
[The literate witness selected by the participant must sign the informed consent form. The witness 
should not have any relationship with the research team; If the participant doesn’t want to disclose 
his / her participation details to others, in view of respecting the wishes of the participant, he / she 
can be allowed to waive from the witness procedure (This is applicable to literate participant ONLY). 
This should be documented by the study staff by getting signature from the prospective participant] 
 
_____________________________________________________________________________________________________ 
 
__________________________   
 
 
“I have witnessed the accurate reading of the consent form to the potential participant 
and the individual has had opportunity to ask questions. I confirm that the individual 
has given consent freely” 
 
 
______________                         __________________                   ____________________ 
Date                                                   Name of the witness                       Signature of the witness 
 
 
______________                        ___________________                  ____________________ 
Date                                                  Name of the  Signature of the interviewer  
  interviewer 
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ANNEURE – 4 
ஒப்புதல் படிவம் 
ஆ஭ாய்ச்சி஬ின் தலயப்பு 
 
இ஭ண்டாம் த஭ பல் வவர் பிரிவு பகுதி எலும்பு வதய்஫ானத்தில் 0.2% லை஬லூவ஭ானிக் 
அ஫ியம் அல஭த்தின்஫க் கல஭சல் உடன் வவரிச் சிலனக்கருச் சவ்வு இலைத்து ப஬ன்படுத்தி 
஫ீல௃ருவாக்கம் திமன் ஫திப்படீு – ஒரு ஫ருத்துவ ஆய்வு 
 
 
 நான் இந்த ஆய்வுக்காக ஈறு அறுலவ சிகிச்லச வசய்து வகாள்ர வவண்டி஬தாக அமிகிவமன். 
 
 சிகிச்லச஬ின் வபாது 0.2% லை஬லூவ஭ானிக் அ஫ியம் அல஭த்தின்஫க் கல஭சல் உடன் வவரிச்   
சிலனக்கருச் சவ்வு இலைத்து ப஬ன்படுத்த சம்஫திக்கிவமன். 
 
 
 
 88 
 
TAMILNADU GOVERNMENT DENTAL COLLEGE & HOSPITAL, 
DEPARTMENT OF PERIODONTICS 
 
 
EVALUATION  OF REGENERATIVE EFFICACY OF 0.2% HYALURONIC ACID 
GEL  IN CONJUNCTION WITH CHORION MEMBRANE IN GRADE II 
FURCATION DEFECT – A CLINICAL  STUDY 
 
PROFORMA FOR TREATMENT GROUP 
Date  :     OP No.:    S.No.: 
Name :     Age :    Sex: 
Occupation :    Income :      
Address :                                              Phone Number :  
 
CHIEF COMPLAINTS AND DURATION: 
 
HISTORY OF PRESENT ILLNESS: 
 
 
PAST MEDICAL HISTORY: 
 
PAST DENTAL HISTORY: 
 
FAMILY HISTORY: 
 
PERSONAL HISTORY  
a) Oral Hygiene Practices : 
b) Habits          : 
ANNEXURE-5 
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c) Menstrual History          : 
d) Menopause          : 
 
e) H/o. Stress Factor         : 
GENERAL EXAMINATION  
a) Extra-Oral Examination: 
 
b) Examination of Lymphnodes: 
INTRA-ORAL EXAMINATION WITH CLINICAL FINDINGS: 
Buccal mucosa: 
Vestibule: 
Hard palate: 
Soft palate: 
Tonsils: 
Tongue: 
Floor of the mouth: 
Teeth 
Decayed: 
Missed: 
Filled teeth: 
Gingiva 
Plaque index 
                
18 17 16 15 14 13 12 11 21 22 23 24 25 26 27 28 
48 47 46 45 44 43 42 41 31 32 33 34 35 36 37 38 
                
Inference: 
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Gingival Bleeding Index 
                
18 17 16 15 14 13 12 11 21 22 23 24 25 26 27 28 
48 47 46 45 44 43 42 41 31 32 33 34 35 36 37 38 
                
Inference: 
 
Periodontal status  
18   17    16    15    14     13    12     11     21    22    23     24     25    26    27    28 
 
48   47     46    45     44    43     42    41     31    32     33    34    35    36    37    38 
CAL  - Clinical Attachment Level         FI       - Furcation Involvement 
                
                
                
                
                
     
 
           
     
 
           
                
                
                
                
                
 
 
Mobility 
PPD  
HPD 
FI 
MO 
FI  
HPD 
B
  
P  
L
  
B
  
CAL 
CAL 
GR 
MO 
GR 
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HPD  - Horizontal Probing Depth          PPD    - Probing Pocket Depth 
GR     - Gingival Recession                    MO    - Mobility 
 
INVESTIGATIONS 
1. Biochemical / Haematological Investigation : 
 
 
 
2. Others : 
Blood Pressure : 
Test Dose for L.A: 
 
RADIOGRAPHIC EVALUATION  
Intra-Oral Periapical Radiograph/Orthopantomogram (IOPA/OPG) 
 
 
PROVISIONAL DIAGNOSIS 
 
PROGNOSIS  
 
TREATMENT PLAN 
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FITNESS FOR TREATMENT  
 
TREATMENT DONE  
PROCEDURE :    
 
 
 
 
 
 
DATE :                                                                           SIGNATURE : 
 
 
MAINTENANCE PHASE 
EVALUATION AFTER - 3 MONTH 
Gingiva 
Plaque index 
                
18 17 16 15 14 13 12 11 21 22 23 24 25 26 27 28 
48 47 46 45 44 43 42 41 31 32 33 34 35 36 37 38 
                
Inference: 
 
 
 
 93 
 
Gingival Bleeding index 
                
18 17 16 15 14 13 12 11 21 22 23 24 25 26 27 28 
48 47 46 45 44 43 42 41 31 32 33 34 35 36 37 38 
                
Inference: 
 
TREATED TOOTH:  
PARAMETERS VALUES IN mm 
PPD  
CAL   
HPD  
 
MAINTENANCE PHASE 
EVALUATION AFTER - 6 MONTHS 
Gingiva 
Plaque index 
                
18 17 16 15 14 13 12 11 21 22 23 24 25 26 27 28 
48 47 46 45 44 43 42 41 31 32 33 34 35 36 37 38 
                
Inference: 
 
Gingival Bleeding index 
                
18 17 16 15 14 13 12 11 21 22 23 24 25 26 27 28 
48 47 46 45 44 43 42 41 31 32 33 34 35 36 37 38 
                
Inference: 
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TREATED  TOOTH: 
PARAMETERS VALUES IN mm  
PPD  
CAL   
HPD  
 
RADIOGRAPHIC ASSESSMENT OF FURCATION DEFECT FILL :  
PARAMETERS BASELINE AFTER 3 MONTHS AFTER 6 MONTHS 
CEJ - BD    
CEJ- FX    
DD    
CF    
BF in mm    
BF%    
 
CEJ- CementoEnamelJunction 
BD- Base of Defect 
FX- Furcation Fornix 
 95 
 
DD- Defect Depth = (CEJ to BD) - (CEJ to FX) 
CF- Correction Factor = 
CEJ  to  FX baseline  
CEJ  to  FX  post −op  
 
BF- Bone Fill = [FX to BD (baseline)] - [FX to BD (post op) x CF] 
BF% = [defect fill/defect depth (baseline)] x 100 
 
 
 
 
 
 
 
                                                               
 
                                                                 
 
 
 
 
 
 
 
                                                                  SIGNATURE OF THE PROFESSOR 
